Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Revenue 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sonoma Pharmaceuticals Inc. revenue for the quarter ending December 31, 2025 was 4.3 M, a 22.03% increase year-over-year.
- Sonoma Pharmaceuticals Inc. revenue for the twelve months ending December 31, 2025 was 17.5 M, a 36.55% increase year-over-year.
- Sonoma Pharmaceuticals Inc. annual revenue for 2025 was 14.3 M, a 12.19% increase from 2024.
- Sonoma Pharmaceuticals Inc. annual revenue for 2024 was 12.7 M, a 4.05% decrease from 2023.
- Sonoma Pharmaceuticals Inc. annual revenue for 2023 was 13.3 M, a 5.10% increase from 2022.
- Sonoma Pharmaceuticals Inc. annual revenue for 2022 was 12.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sonoma Pharmaceuticals Inc. Market Cap — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) market cap over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNOA's market cap history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.